Japan University in Novartis Diovan Trials Denies Data Manipulated
This article was originally published in PharmAsia News
Executive Summary
Japan's Nagoya University became the first of five schools implicated in a data-manipulation scandal involving a Novartis drug to deny that data from the clinical trials it conducted had been changed.